Product Code: ETC7749946 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Transcatheter Aortic Valve Implantation (TAVI) market in Japan is witnessing significant growth driven by the rising prevalence of cardiovascular diseases, technological advancements in minimally invasive procedures, and an aging population. The demand for TAVI procedures is increasing as they offer a less invasive alternative to traditional open-heart surgeries, leading to quicker recovery times and better patient outcomes. Key players in the Japan TAVI market include Medtronic, Edwards Lifesciences, and Boston Scientific Corporation, who are continuously investing in research and development activities to introduce innovative TAVI devices. The market is also benefiting from favorable reimbursement policies and increasing awareness among healthcare professionals and patients about the benefits of TAVI procedures, positioning Japan as a key market for TAVI technologies in the Asia-Pacific region.
The Japan TAVI (Transcatheter Aortic Valve Implantation) market is experiencing significant growth due to the rising prevalence of cardiovascular diseases, an aging population, and technological advancements in minimally invasive procedures. Key trends include an increasing adoption of TAVI as a preferred treatment option over traditional open-heart surgery, expansion of indications for TAVI to include low-risk patients, and the development of next-generation devices with improved outcomes. Opportunities in the Japan TAVI market lie in collaborations between medical device companies and healthcare providers to enhance patient access, continued research and development to improve device efficacy and safety, and strategic partnerships to expand market presence. With a supportive regulatory environment and growing acceptance of TAVI among physicians and patients, the Japan TAVI market is poised for further growth and innovation.
In the Japan Tavi market, some of the key challenges include regulatory hurdles related to the approval process for new technologies, cultural resistance to adopting innovative medical procedures, and the high cost of Tavi procedures compared to traditional treatment options. Additionally, there is a shortage of skilled healthcare professionals with expertise in performing Tavi procedures, leading to limited access to these services in certain regions. Another challenge is the need for continued research and development to improve the efficacy and safety of Tavi devices, as well as to expand the range of eligible patients for this minimally invasive treatment. Overall, overcoming these challenges will require collaboration between industry stakeholders, healthcare providers, and regulatory bodies to ensure the successful growth and adoption of Tavi in Japan.
The Japan Tavi market is primarily driven by the increasing prevalence of valvular heart disease, particularly among the aging population. The rising incidence of risk factors such as hypertension, diabetes, and obesity is further fueling the demand for Transcatheter Aortic Valve Implantation (TAVI) procedures as a less invasive alternative to traditional open-heart surgery. Technological advancements in TAVI devices, leading to improved patient outcomes and reduced recovery times, are also contributing to market growth. Additionally, the growing adoption of TAVI procedures by healthcare providers due to their cost-effectiveness and efficacy in treating high-risk patients who are not suitable for surgery is boosting market expansion in Japan.
The Japan TAVR (Transcatheter Aortic Valve Replacement) market is mainly regulated by the Ministry of Health, Labour and Welfare (MHLW) in Japan. The MHLW has established guidelines and regulations for the approval and reimbursement of TAVR procedures, ensuring patient safety and quality of care. The government`s policies focus on expanding access to TAVR technology and promoting innovation in the field of cardiovascular healthcare. Additionally, the MHLW regularly reviews and updates reimbursement rates for TAVR procedures to maintain cost-effectiveness and sustainability within the healthcare system. Overall, government policies in Japan aim to support the growth of the TAVR market while prioritizing patient outcomes and healthcare affordability.
The Japan Tavi market is expected to witness significant growth in the coming years, driven by the increasing prevalence of valvular heart diseases and the growing elderly population in the country. Technological advancements in Tavi procedures, such as improved device designs and imaging techniques, are also expected to contribute to market growth. Additionally, the rising adoption of minimally invasive procedures and the favorable reimbursement policies for Tavi in Japan are likely to fuel market expansion. With a strong healthcare infrastructure and a focus on innovation, the Japan Tavi market is poised for continued growth and presents lucrative opportunities for market players in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Tavi Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Tavi Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Tavi Market - Industry Life Cycle |
3.4 Japan Tavi Market - Porter's Five Forces |
3.5 Japan Tavi Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Tavi Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Japan Tavi Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Japan |
4.2.2 Growing adoption of minimally invasive procedures |
4.2.3 Technological advancements in transcatheter aortic valve implantation (TAVI) devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for medical devices in Japan |
4.3.2 High cost associated with TAVI procedures |
4.3.3 Limited reimbursement policies for TAVI in Japan |
5 Japan Tavi Market Trends |
6 Japan Tavi Market, By Types |
6.1 Japan Tavi Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Tavi Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Tavi Market Revenues & Volume, By Less than 20mm, 2021- 2031F |
6.1.4 Japan Tavi Market Revenues & Volume, By 20-25mm, 2021- 2031F |
6.1.5 Japan Tavi Market Revenues & Volume, By Great than 25mm, 2021- 2031F |
6.2 Japan Tavi Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Tavi Market Revenues & Volume, By Elderly Patients, 2021- 2031F |
6.2.3 Japan Tavi Market Revenues & Volume, By Other Patients, 2021- 2031F |
7 Japan Tavi Market Import-Export Trade Statistics |
7.1 Japan Tavi Market Export to Major Countries |
7.2 Japan Tavi Market Imports from Major Countries |
8 Japan Tavi Market Key Performance Indicators |
8.1 Average procedure time for TAVI in Japan |
8.2 Number of hospitals offering TAVI procedures |
8.3 Patient satisfaction rates post-TAVI treatment |
9 Japan Tavi Market - Opportunity Assessment |
9.1 Japan Tavi Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Tavi Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Japan Tavi Market - Competitive Landscape |
10.1 Japan Tavi Market Revenue Share, By Companies, 2024 |
10.2 Japan Tavi Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |